Hamid Khoja is the Chief Scientific Officer of FibroBiologics which is developing regenerative medicine using fibroblasts which are one of the most abundant cells in the human body. While stem cell therapy has gotten significant attention, fibroblasts are easier to source and grow. Hamid elaborates, “Just to give you a sense of some of the capabilities […]

Although things appeared to quiet down for COVID-19-related clinical trial news, there were plenty of announcements for other indications. Here’s a look. COVID-19-Related Veru reported the Independent Data Monitoring Committee (IDMC) planned a conditional power analysis of the first 75 patients in its Phase III COVID-19 registration trial of sabizabulin. The trial studied the drug’s effects in […]

It’s a tough market right now for biotech IPOs, but one small company is taking the public leap Friday with a modest initial offering. Blue Water Vaccines raised $20 million in its IPO, pricing shares at $9 apiece late Thursday afternoon. The Cincinnati-based company will use the money primarily to advance a slate of preclinical […]